Study of AR-12286 Versus Latanoprost in Patients With Elevated Intraocular Pressure

NCT01060579 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

217

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma

Interventions

DRUG: AR-12286 0.5% ophthalmic solution
DRUG: AR-12286 0.25% Ophthalmic solution
DRUG: Latanoprost ophthalmic solution

Sponsor

Aerie Pharmaceuticals